pre-seed
Stage
About
AdipoPharma is a biotechnology company developing PATAS, a first-in-class therapeutic peptide targeting adipocyte cells to treat insulin resistance, type 2 diabetes, and related metabolic comorbidities by restoring lipid homeostasis and improving metabolic health.
Explore AdipoPharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.